Company: PMVP
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001140361-25-015610
Chunk: 45

Company: PMV Pharmaceuticals, Inc.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 45
---
 |    345,034 |     |    153,264 |     |    595,843 |
| Change in Fair Value of Existing Unvested Equity Awards(2)                        |     |     41,003 |     |   -294,421 |     | -1,621,768 |
| Change in Fair Value of Vested Equity Awards                                      |     |    -27,022 |     |   -150,170 |     |   -694,801 |
| Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year     |     |     66,948 |     |     65,365 |     |    168,763 |
| Compensation Actually Paid to NEOs                                                |     | $1,011,546 |     |   $399,137 |     | $(599,868) |

| (1) | Represents the grant fair value of the equity awards to our NEOs, as reported in the SCT. |

| (2) | In August 2024, in connection with the Company offering of a one-time voluntary stock option exchange to its employees, stock options held by our CEO and Non-CEO NEOs were exchanged for new stock options with an exercise price equal to $1.48per share and a new vesting schedule (“Option Exchange”), with all other terms remaining the same. The incremental change in fair value related to the Option Exchange is reflected within this row. |

26

TABLE OF CONTENTS The following graphs illustrate the relationship during 2022-2024 of the CAP for our PEO and the average CAP for our other NEOs as calculated pursuant to SEC rules to (i) our total shareholder return (“TSR”) and (ii) our net income (loss) (each as set forth in the table above). Note that we do not utilize TSR or net income (loss) in our executive compensation program; however, we do utilize several other performance measures to align executive compensation with the Company’s performance. All information provided above under the “Pay Versus Performance” heading will not be deemed to be incorporated by reference into any filing of PMV Pharmaceuticals under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing, except to the extent we specifically incorporate such information by reference. 27

TABLE OF CONTENTS

Equity Compensation Plan Information The following table